When was Ethypharm founded?

Ethypharm was founded in 1977 and raised its 1st funding round 25 years after it was founded.

Where is Ethypharm located?

Ethypharm is headquartered in Saint Cloud, France.

How many employees does Ethypharm have?

As of Sep 30, 2026, the latest employee count at Ethypharm is 1136.

Is Ethypharm a funded company?

Ethypharm is a funded company, having raised a total of $248M across 5 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Apr 15, 2002.

How much is Ethypharm worth?

The last known valuation of Ethypharm was $***** as of May 07, 2016.

When was the latest funding round of Ethypharm?

Ethypharm's latest funding was a $***** Grant (prize money) round on Dec 21, 2023, with participation from 1 investor.

Where does Ethypharm rank among its competitors?

Ethypharm ranks 6th amongst 56 active competitors, of which 15 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Kinoxis Therapeutics, which secured $4.8M in Sep, 2026.

Who are the top competitors of Ethypharm?

Ethypharm's top competitors include Indivior, Braeburn and Adial Pharmaceuticals. Among them, Kinoxis Therapeutics secured the most recent funding round in September, 2026.

Ethypharm - 2026 Company Profile, Funding & Competitors

Q: Is Ethypharm an acquired company?

Ethypharm got acquired by PAI Partners on May 07, 2016.

Company Details

Ethypharm is developing drugs and drug delivery systems (DDS) to treat pain and addiction. The company has developed a drug portfolio such as Morphine, Fentanyl, Tramadol, oxycodone, oxycodone hydrochloride, Etodolac-Lodine, Triamcinolone Hexacetonide, and Episil for treating pain. The company is also developing drugs for alcohol dependence, overdose, and opioid replacement.

Website: www.ethypharm.com/
Social
Email ID: *****@ethypharm.com

Key Metrics

Founded Year

1977

Location

Saint Cloud, France

Stage

Acquired

Total Funding

$248M in 5 rounds

Latest Funding Round

Grant (prize money), Dec 21, 2023, $*****

Last Known Valuation

$***** as on May 07, 2016

Investors

Biovail & 8 more

Ranked

6^th among 56 active competitors

Employee Count

1,136 as on Sep 30, 2026

Investment & Acquisitions

Martindale Pharma & 2 more

Similar Companies

Indivior & 61 more

Exit Details

Acquired by PAI Partners (May 07, 2016)

View Ethypharm's full profile

Ethypharm got acquired by PAI Partners on May 07, 2016 at an acquisition amount of $*****.

Click here to take a look at Ethypharm's acquisition in detail

Ethypharm has raised a total funding of $248M over 5 rounds. Its first funding round was on Apr 15, 2002. Its latest funding round was a Grant (prize money) round on Dec 21, 2023 for $*****. 1 investor participated in its latest round. Ethypharm has 9 institutional investors.

Here is the list of recent funding rounds of Ethypharm:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 21, 2023	2135045	Grant (prize money)	3171220	7867598	7981602	4025398
Apr 10, 2021	3714616	Grant (prize money)	8047948	3714902	4540116	Economy And Finance
Sep 30, 2015	8063740	Conventional Debt	3847155	6588063	5208298	J P Morgan & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Ethypharm's funding rounds and investors

Ethypharm's employee count trend

Ethypharm has 1,136 employees as of Sep 26. Here is Ethypharm's employee count trend over the years:

Uncover Ethypharm's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ethypharm include Indivior, Braeburn and Adial Pharmaceuticals. Here is the list of Top 10 competitors of Ethypharm, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indivior 2014, Richmond Hill (United States), Public	Therapeutics for addiction treatment	-	Digital Pharma Lab, Athyrium Capital Management ... & 1 others	61/100
2nd	Braeburn 2012, Philadelphia (United States), Series D	Developing long acting formulation for opioid addiction	$110M	RA Capital Management, New Leaf Venture Partners ... & 5 others	58/100
3rd	Adial Pharmaceuticals 2010, Charlottesville (United States), Public	Developer of therapeutics for the treatment of addictions	$7.7M	Coastlands Capital, Boxer Capital & 3 others	57/100
4th	Aelis Farma 2013, Bordeaux (France), Public	Developer of small molecule drugs targeting CB1 receptor for CNS diseases	$14M	Bpifrance, Inserm Transfert & 10 others	56/100
5th	Achieve Life Sciences 1991, Seattle (United States), Public	Developer of plant-based alkaloid for treating smoking cessation	-	Marshall Wace, Frazier Life Sciences & 7 others	56/100
6th	Ethypharm 1977, Saint Cloud (France), Acquired	Developer of therapies for the treatment of pain and addiction	$248M	Goldman Sachs, Astorg Partners & 7 others	57/100
7th	Kinoxis Therapeutics 2017, Melbourne (Australia), Series B	Developer of therapies fort treating CNS disorders	$18.2M	Uniseed, UniSuper & 6 others	54/100
8th	Myosin Therapeutics 2020, Jupiter (United States), Seed	Developer of therapeutics for CNS-based disorders	$6M	Florida Opportunity Fund, DeepWork Capital ... & 7 others	53/100
9th	Biotie 1998, Turku (Finland), Acquired	Commercial Stage biotech company developing drugs against CNS disease.	$150M	Foresite Capital, Versant Ventures & 10 others	50/100
10th	DemeRx 2010, Miami (United States), Series A	Developer of non-addicting alternatives for opioid de-addiction	$5.43M	-	49/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Ethypharm's competitors? Click here to see the top ones

Ethypharm has acquired 3 companies including Martindale Pharma, DB Ashbourne and Martindale Pharma. Ethypharm has not made any investments as of now.

Here is the list of its acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 19, 2017	Acquisition	Martindale Pharma	1787	Wooburn Green (United Kingdom)
Oct 01, 2015	Acquisition	DB Ashbourne	2010	United Kingdom
Jun 01, 2010	Acquisition	Martindale Pharma	1787	Wooburn Green (United Kingdom)